bristoldrv Posted January 17, 2019 Report Share Posted January 17, 2019 Lilly-Loxo Deal Puts Precision Medicine Biotechs Up For Grabs Investor's Business DailyOncology assets, including precision medicine biotechs, could be on the table after Lilly put up an $8 billion bid for Loxo, an analyst says. View the full article Quote Link to comment Share on other sites More sharing options...